JP2016502980A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502980A5
JP2016502980A5 JP2015546771A JP2015546771A JP2016502980A5 JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5 JP 2015546771 A JP2015546771 A JP 2015546771A JP 2015546771 A JP2015546771 A JP 2015546771A JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5
Authority
JP
Japan
Prior art keywords
agent according
respiratory disease
cells
stro
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015546771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502980A (ja
JP6313327B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/001454 external-priority patent/WO2014089625A1/en
Publication of JP2016502980A publication Critical patent/JP2016502980A/ja
Publication of JP2016502980A5 publication Critical patent/JP2016502980A5/ja
Application granted granted Critical
Publication of JP6313327B2 publication Critical patent/JP6313327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015546771A 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法 Active JP6313327B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018055386A Division JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法

Publications (3)

Publication Number Publication Date
JP2016502980A JP2016502980A (ja) 2016-02-01
JP2016502980A5 true JP2016502980A5 (cg-RX-API-DMAC7.html) 2017-02-02
JP6313327B2 JP6313327B2 (ja) 2018-04-18

Family

ID=50933587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015546771A Active JP6313327B2 (ja) 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Country Status (11)

Country Link
US (3) US10028979B2 (cg-RX-API-DMAC7.html)
EP (1) EP2931373B1 (cg-RX-API-DMAC7.html)
JP (5) JP6313327B2 (cg-RX-API-DMAC7.html)
KR (1) KR101748712B1 (cg-RX-API-DMAC7.html)
CN (2) CN115919901A (cg-RX-API-DMAC7.html)
AU (4) AU2013360026B2 (cg-RX-API-DMAC7.html)
CA (1) CA2893951C (cg-RX-API-DMAC7.html)
ES (1) ES2759281T3 (cg-RX-API-DMAC7.html)
IL (1) IL239309A0 (cg-RX-API-DMAC7.html)
SG (2) SG11201504352TA (cg-RX-API-DMAC7.html)
WO (1) WO2014089625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
JP2020533373A (ja) * 2017-09-15 2020-11-19 サイナータ セラピューティクス リミテッド アレルギー性気道疾患(aad)/喘息の処置方法
TW202146033A (zh) * 2020-01-30 2021-12-16 日商Jcr製藥股份有限公司 包含源自牙髓的細胞之醫藥組成物
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US20050118714A1 (en) * 2002-02-19 2005-06-02 Chul-Won Ha Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN102391981B (zh) * 2004-09-24 2014-08-20 麦索布莱斯特公司 多能扩增间充质前体细胞子代(memp)及其应用
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
ES2923016T3 (es) * 2007-08-06 2022-09-22 Mesoblast Inc Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo
JP5539886B2 (ja) * 2007-10-17 2014-07-02 ティクセル Tr1細胞、間葉系幹細胞およびその使用
US8828375B2 (en) * 2008-09-03 2014-09-09 Mesoblast, Inc. Expansion of haemopoietic precursors
AU2011274255B2 (en) * 2010-07-02 2016-05-05 Mesoblast, Inc. Treatment of T-cell mediated immune disorders
KR101947699B1 (ko) * 2011-03-11 2019-02-14 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
CA2837895C (en) * 2011-06-03 2021-07-27 Mesoblast, Inc. Methods of treating or preventing neurological diseases
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Similar Documents

Publication Publication Date Title
JP2016502980A5 (cg-RX-API-DMAC7.html)
JP2014507482A5 (cg-RX-API-DMAC7.html)
Zhong et al. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis
Pappas et al. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
RU2015143254A (ru) Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
JP2008513467A5 (cg-RX-API-DMAC7.html)
EA201390049A1 (ru) Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы
CO6020017A1 (es) Forma galenica divisible que permite una liberacion modificada del principio activo
PE20141012A1 (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
SG10201807682PA (en) Methods of Treating or Preventing Respiratory Conditions
Wang et al. Deciphering the effects of 2D black phosphorus on disrupted hematopoiesis and pulmonary immune homeostasis using a developed flow cytometry method
JP2013507945A5 (cg-RX-API-DMAC7.html)
EP2120935A4 (en) NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
JP2016504311A5 (cg-RX-API-DMAC7.html)
van Echteld et al. A view on imaging in drug research and development for respiratory diseases
Krimmer et al. Exposure To Biomass Smoke Extract Enhances Fibronectin Release From Human Lung Fibroblasts
JP2013194009A5 (cg-RX-API-DMAC7.html)
CN201879100U (zh) 一种桌子
JP2018510153A5 (cg-RX-API-DMAC7.html)